Abstract Key Points 1 Liver failure and liver cancer from chronic hepatitis C are the most
common indications for liver transplantation and numbers of both are projected to double …

Hepatitis C virus (HCV) infection is a prevalent infection in most developed countries
affecting 1.5–2% of the general population [1]. The natural history of this infection has been …

Past exposure to hepatitis C virus (HCV) is mostly determined by testing for specific
antibodies using an approved enzyme immunoassay (EIA). The presence of antibody shows …

Since liver transplantation was approved for the treatment of end stage liver disease,
calcineurin inhibitors (CNI′ s) have played a critical role in the preservation of allograft …

Background Infection with the hepatitis C virus (HCV) has been considered a major cause of
mortality, morbidity and resource utilisation in the US. In addition, HCV is the main cause of …

This EASL monothematic conference aimed to review in a 2-day meeting the most recent
aspects of liver transplantation for viral hepatitis. Experts from Europe and overseas …

The variable impact of specific risk factors on survival outcomes based on pre-
transplantation diagnosis was analyzed in adult liver transplant recipients reported to the …

Post‐transplantation recurrence is increasing in patients with HCV. Early antiviral therapy
may be of benefit in this setting. Thus, accurate and early prediction of progression may help …

BACKGROUNDS/AIMS: Recurrent HCV-cirrhosis occurs in a substantial proportion of
transplant recipients, with higher rates reported in patients who had recently received a …

A controversy exists over whether the outcome of a hepatitis C virus (HCV)‐infection‐related
liver transplant differs based on the calcineurin inhibitor (CNI) used. We have performed a …